Skip to main content

Table 3 Unadjusted analysis of selected predictors for 30-days mortality and all-cause mortality

From: The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients

  30 - days mortality All- cause mortality
OR 95% CI p-value OR 95% CI p-value
Ribotype 001 0.6 0.3–1.1 0.07 0.4 0.3–0.7 0.00
Ribotype 176 0.7 0.3–1.4 0.29 0.8 0.4–1.6 0.53
Binary toxin genes 1.1 0.5–2.2 0.80 0.9 0.5–1.7 0.75
Moxifloxacin (RS) 2.4 1.3–4.3 0.00 2.9 1.7–4.9 0.00
Age 1.0 1.0–1.0 0.01 1.0 1.0–1.0 0.00
Gender 2.0 1.1–3.5 0.02 1.5 0.9–2.4 0.11
CDI Origin 1.8 0.5–6.2 0.33 1.6 0.6–4.4 0.32
Complicated CDI 4.5 2.4–8.4 0.00 4.2 2.4–7.4 0.00
  1. CDI Clostridium difficile infection, CI confidential interval, OR Odds ratio, RS reduced susceptibility